Variant report
Variant | esv3426499 |
---|---|
Chromosome Location | chr4:187880374-187891619 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs138074403 | chr4:187880377-187880378 | Weak transcription Enhancers Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
2 | rs149041635 | chr4:187880384-187880385 | Weak transcription Enhancers Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
3 | rs13119348 | chr4:187880397-187880398 | Weak transcription Enhancers Bivalent Enhancer | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
4 | rs114455250 | chr4:187880410-187880411 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs549207770 | chr4:187880413-187880414 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs559506510 | chr4:187880418-187880419 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs77119715 | chr4:187880421-187880422 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs13119386 | chr4:187880436-187880437 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
9 | rs145755191 | chr4:187880437-187880438 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs577667253 | chr4:187880456-187880457 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs13120002 | chr4:187880472-187880473 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs536660147 | chr4:187880475-187880476 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs62343157 | chr4:187880477-187880478 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs13119419 | chr4:187880478-187880479 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs536341928 | chr4:187880482-187880483 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs553236509 | chr4:187880484-187880485 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs113862789 | chr4:187880500-187880501 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs111730135 | chr4:187880503-187880504 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs572927936 | chr4:187880507-187880508 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs190865385 | chr4:187880508-187880509 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs558593098 | chr4:187880510-187880511 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs113202758 | chr4:187880520-187880521 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs13124773 | chr4:187880527-187880528 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs112214449 | chr4:187880532-187880533 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs13124782 | chr4:187880536-187880537 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs13124968 | chr4:187880537-187880538 | Weak transcription | n/a | n/a | Overlapped CNVs | mRNA abundance |
27 | rs13124985 | chr4:187880559-187880560 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs575454851 | chr4:187880560-187880561 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs113139746 | chr4:187880562-187880563 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs543413762 | chr4:187880572-187880573 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs111454261 | chr4:187880580-187880581 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs183005000 | chr4:187880587-187880588 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs78760414 | chr4:187880594-187880595 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs75488575 | chr4:187880597-187880598 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs113983775 | chr4:187880601-187880602 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs528698211 | chr4:187880609-187880610 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs112843929 | chr4:187880610-187880611 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs112566592 | chr4:187880621-187880622 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs113591468 | chr4:187880624-187880625 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs113187541 | chr4:187880631-187880632 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs112032284 | chr4:187880639-187880640 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs113760103 | chr4:187880650-187880651 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs113734229 | chr4:187880653-187880654 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs111830486 | chr4:187880660-187880661 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs543474418 | chr4:187880677-187880678 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs111353891 | chr4:187880680-187880681 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs111677590 | chr4:187880683-187880684 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs545546376 | chr4:187880685-187880686 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs112885722 | chr4:187880697-187880698 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs565330130 | chr4:187880698-187880699 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Acute lymphoblastic leukemia | 22237106 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Chordoma | 21602918 | CNVD |
HIV/AIDS | 22032296 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Breast cancer | 21858162 | CNVD |
Small bowel adenocarcinoma | 21586687 | CNVD |
Gastric cancer | 21586687 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Malignant mesothelioma | 18160781 | CNVD |
Medulloblastoma | 18056178 | CNVD |
Multiple myeloma | 17077331 | CNVD |
Pleural malignant mesothelioma | 18160781 | CNVD |
Primary mediastinal b-cell lymphoma | 17728785 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
4q-syndrome | 17576883 | CNVD |
Cancer | 21637783 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Muscular dystrophy | 21149563 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Liposarcoma | 21253554 | CNVD |
Oligodendroglial tumors | 17285580 | CNVD |
Cervical cancer | 21062161 | CNVD |
Breast cancer | 16608533 | CNVD |
Wilms tumour | 21544195 | CNVD |
Lung cancer | 18438408 | CNVD |
Cancer | 22429812 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Breast cancer | 16272173 | CNVD |
Breast cancer | 17133270 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Congenital anomalies of the kidney and urinary tract | 20505237 | CNVD |
Testicular germ cell tumor | 18059402 | CNVD |
Ovarian cancer | 22174824 | CNVD |
Olfactory neuroblastoma | 18408657 | CNVD |
Breast cancer | 21785460 | CNVD |
Hodgkin''s lymphoma | 18641027 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
small cell lung cancer | 20016488 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Breast cancer | 21633010 | CNVD |
Invasive pancreatic ductal carcinoma | 16982739 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Cancer | 20581869 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
abnormal development | 18461090 | CNVD |
Neuroblastoma | 16790693 | CNVD |
Colorectal cancer | 16774939 | CNVD |
Congenital anomalies of the kidney and urinary tract | 18316590 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Facioscapulohumeral muscular dystrophy | 21829175 | CNVD |
Disorders of sex development | 21048976 | CNVD |
Ovarian cancer | 20844748 | CNVD |
Autism | 18414403 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Cancer | 20164920 | CNVD |
Cancer | 20164919 | CNVD |
Breast cancer | 20409316 | CNVD |
Rhabdomyosarcoma | 16790082 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Schizophrenia | 21399695 | CNVD |
Developmental delay | 22127048 | CNVD |
Acute lymphoblastic leukemia | 21098271 | CNVD |
Cervical cancer | 21063398 | CNVD |
Oral cancer | 21386901 | CNVD |
Breast cancer | 22522925 | CNVD |
Pancreatic cancer | 17952125 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr4:187868400-187880800 | Weak transcription | H1 Derived Mesenchymal Stem Cells | ES cell derived |
2 | chr4:187879400-187880400 | Enhancers | Breast Myoepithelial Primary Cells | Breast |
3 | chr4:187880000-187880400 | Enhancers | IMR90 fetal lung fibroblasts Cell Line | lung |
4 | chr4:187880200-187880400 | Bivalent Enhancer | NHEK | skin |